Fig. 4From: Impact of teneligliptin on oxidative stress and endothelial function in type 2 diabetes patients with chronic kidney disease: a case–control studyChanges in d-ROMs in both groups (a); comparison of percent change in d-ROMs (b). Percent change in d-ROMs: [d-ROMs after 24 weeks of treatment—d-ROMs before treatment]/baseline d-ROMs value. A biomarker of oxidative stress, d-ROMS, significantly decreased in the teneligliptin group. The percent change in d-ROMs in the teneligliptin group was slightly lower than that in the sitagliptin groupBack to article page